When given after organ-removal surgery, Keytruda brings patients battling advanced bladder cancers more time cancer-free, a new trial finds.
Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby...
Britain's King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday.
"His Majesty The King will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report.
People who've gotten surgery for high-risk bladder cancer require a cystoscopy -- a procedure in which a flexible ...
A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show.
Patients who took a combo of meds called EV+P -- enfortumab vedotin and pembrolizumab (Keytruda) -- had an average 31.5 months surviva...
"Listen, I'm not a Pollyanna,"New Yorker David Cabelis makes clear. "I'm a cab driver."
"But I was diagnosed with this cancer,"the 72-year old said. "Bladder cancer, that's what I had, and then I had this treatment, and it was the most amazing experience. And thank God, ...
It's common knowledge that loss is a part of male aging -- loss of hair, loss of muscle tone, loss of vision or hearing.
But men growing older also start losing the very thing that makes them biological males, their Y chromosome, and that can leave them more vulnerable t...
For years, doctors have thought that a more extensive surgery that removes a wider swath of lymph nodes was the best option for certain patients with bladder cancer. Now, a new clinical trial is upending that belief.
Researchers found that the strategy -- known as exten...
Patients with a high-risk bladder cancer now have a new option to treat it.
The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who have what's called high-risk non-muscle-invasive bladder can...
The latest statistics from the U.S. National Cancer Institute (NCI) show a continuing decline in the number of Americans who die from cancer, although there's been little change in the number of new cancer cases.
"From 2015 to 2019, overall cancer death rates decreased b...
Football Hall of Famer Terry Bradshaw revealed Sunday that he has been treated for two different types of cancer in the past year.
Immunotherapy with nivolumab (Opdivo) after surgery for metastatic bladder cancer significantly reduces the odds for the tumor's return, a new clinical trial finds.
The early months of the COVID-19 pandemic kept millions of Americans away from routine cancer screenings. Now a new study finds that many U.S. screening programs were still not back to normal by 2021.
The study, of more than 700 cancer facilities nationwide, found that i...
New research offers fresh proof that the COVID-19 pandemic delayed cancer diagnoses in the United States, increasing patients' risk for poor outcomes.
For the study, researchers analyzed data from more than 9 million patients at over 1,200 Veterans Affairs (VA) medical f...
Private insurers paid out about $156.2 billion in 2018 for U.S. patients with the 15 most common cancers.
Medication was the largest expense and drugs for breast, lung, lymphoma and colon cancers accounted for the largest chunk of those costs, according to a Penn State C...